Relationships between right ventricular function, body composition, and prognosis in advanced heart failure

Journal of the American College of Cardiology

Volumn 62, Issue 18, 2013, Pages 1660-1670

  Melenovsky, Vojtech ^a,b   Kotrc, Martin ^a   Borlaug, Barry A ^b   Marek, Tomas ^a   Kovar, Jan ^a   Malek, Ivan ^a   Kautzner, Josef ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b MAYO CLINIC   (United States)

Author keywords

body composition; cachexia; heart failure; obesity paradox; right ventricular function

Indexed keywords

ADIPONECTIN; BRAIN NATRIURETIC PEPTIDE; LEPTIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; CACHEXIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; EVENT FREE SURVIVAL; FAT MASS; FAT MASS TO LEAN BODY MASS RATIO; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART OUTPUT; HEART RATE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RISK ASSESSMENT; SKINFOLD THICKNESS; SURVIVAL PREDICTION; TRICUSPID VALVE REGURGITATION; WEIGHT REDUCTION;

B-TYPE NATRIURETIC PEPTIDE; BMI; BNP; BODY COMPOSITION; BODY MASS INDEX; CACHEXIA; CI; CONFIDENCE INTERVAL; DEXA; DUAL-ENERGY X-RAY ABSORPTIOMETRY; HAZARD RATIO; HEART FAILURE; HF; HR; LEFT VENTRICULAR; LV; OBESITY PARADOX; RIGHT VENTRICULAR; RIGHT VENTRICULAR DYSFUNCTION; RIGHT VENTRICULAR FUNCTION; RV; RVD;

ADIPONECTIN; AGE FACTORS; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS INDEX; CACHEXIA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HEART RATE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84886414570     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.06.046     Document Type: Article

References (50)

1. S. Kenchaiah, J.C. Evans, and D. Levy Obesity and the risk of heart failure N Engl J Med 347 2002 305 313
2. C.J. Lavie, M.A. Alpert, R. Arena, M.R. Mehra, R.V. Milani, and H.O. Ventura Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure J Am Coll Cardiol HF 1 2013 93 102
3. J.P. Curtis, J.G. Selter, and Y. Wang The obesity paradox: body mass index and outcomes in patients with heart failure Arch Intern Med 165 2005 55 61
4. S. Kenchaiah, S.J. Pocock, and D. Wang Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program Circulation 116 2007 627 636
5. G.C. Fonarow, P. Srikanthan, M.R. Costanzo, G.B. Cintron, and M. Lopatin An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry Am Heart J 153 2007 74 81
6. C.J. Lavie, A.F. Osman, R.V. Milani, and M.R. Mehra Body composition and prognosis in chronic systolic heart failure: the obesity paradox Am J Cardiol 91 2003 891 894
7. T.B. Horwich, G.C. Fonarow, M.A. Hamilton, W.R. MacLellan, M.A. Woo, and J.H. Tillisch The relationship between obesity and mortality in patients with heart failure J Am Coll Cardiol 38 2001 789 795
8. S.D. Anker, A. Negassa, and A.J. Coats Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083
9. S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
10. J.G. Carr, L.W. Stevenson, J.A. Walden, and D. Heber Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 63 1989 709 713
11. J.G. Pittman, and P. Cohen The pathogenesis of cardiac cachexia N Engl J Med 271 1964 403 409
12. S.D. Anker, P.P. Ponikowski, and A.L. Clark Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure Eur Heart J 20 1999 683 693
13. A. Sandek, J. Bauditz, and A. Swidsinski Altered intestinal function in patients with chronic heart failure J Am Coll Cardiol 50 2007 1561 1569
14. E.T. Poehlman, J. Scheffers, S.S. Gottlieb, M.L. Fisher, and P. Vaitekevicius Increased resting metabolic rate in patients with congestive heart failure Ann Intern Med 121 1994 860 862
15. V.G. Florea, M.Y. Henein, and M. Rauchhaus The cardiac component of cardiac cachexia Am Heart J 144 2002 45 50
16. M.B. McEntegart, B. Awede, and M.C. Petrie Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide Eur Heart J 28 2007 829 835
17. J. McMurray, I. Abdullah, H.J. Dargie, and D. Shapiro Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure Br Heart J 66 1991 356 358
18. A. Gavazzi, C. Berzuini, and C. Campana Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure J Heart Lung Transplant 16 1997 774 785
19. S. Ghio, A. Gavazzi, and C. Campana Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 2001 183 188
20. A.A. Ajayi, A.Q. Adigun, E.O. Ojofeitimi, H. Yusuph, and O.E. Ajayi Anthropometric evaluation of cachexia in chronic congestive heart failure: the role of tricuspid regurgitation Int J Cardiol 71 1999 79 84
21. N.F. Voelkel, R.A. Quaife, and L.A. Leinwand Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure Circulation 114 2006 1883 1891
22. R.M. Lang, M. Bierig, and R.B. Devereux Recommendations for chamber quantification Eur J Echocardiogr 7 2006 79 108
23. S. Kaul, C. Tei, J.M. Hopkins, and P.M. Shah Assessment of right ventricular function using two-dimensional echocardiography Am Heart J 107 1984 526 531
24. J. Meluzin, L. Spinarova, and J. Bakala Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion: a new, rapid, and non-invasive method of evaluating right ventricular systolic function Eur Heart J 22 2001 340 348
25. J.V. Durnin, and J. Womersley Total body fat, calculated from body density, and its relationship to skinfold thickness in 571 people aged 12-72 years Proc Nutr Soc 32 1973 45A
26. Y. Schutz, U.U. Kyle, and C. Pichard Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y Int J Obes Relat Metab Disord 26 2002 953 960
27. W.J. Evans, J.E. Morley, and J. Argiles Cachexia: a new definition Clin Nutr 27 2008 793 799
28. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
29. S. Fulster, M. Tacke, and A. Sandek Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF) Eur Heart J 34 2013 512 519
30. P. de Groote, A. Millaire, and C. Foucher-Hossein Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure J Am Coll Cardiol 32 1998 948 954
31. J. Meluzin, L. Spinarova, and P. Hude Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure J Am Soc Echocardiogr 18 2005 435 444
32. R.V. Desai, P. Meyer, and M.I. Ahmed Relationship between left and right ventricular ejection fractions in chronic advanced systolic heart failure: insights from the BEST trial Eur J Heart Fail 13 2011 392 397
33. D. King, M.L. Smith, T.J. Chapman, H.R. Stockdale, and M. Lye Fat malabsorption in elderly patients with cardiac cachexia Age Ageing 25 1996 144 149
34. W. Strober, L.S. Cohen, T.A. Waldmann, and E. Braunwald Tricuspid regurgitation. A newly recognized cause of protein-losing enteropathy, lymphocytopenia and immunologic deficiency Am J Med 44 1968 842 850
35. J. Niebauer, H.D. Volk, and M. Kemp Endotoxin and immune activation in chronic heart failure: a prospective cohort study Lancet 353 1999 1838 1842
36. J. Polak, M. Kotrc, and Z. Wedellova Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls J Am Coll Cardiol 58 2011 1119 1125
37. T. Yamauchi, J. Kamon, and Y. Minokoshi Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nature Med 8 2002 1288 1295
38. C. Kistorp, J. Faber, and S. Galatius Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762
39. F. Haddad, R. Doyle, D.J. Murphy, and S.A. Hunt Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure Circulation 117 2008 1717 1731
40. V. Melenovsky, M. Kotrc, and J. Polak Availability of energetic substrates and exercise performance in heart failure with or without diabetes Eur J Heart Fail 14 2012 754 763
41. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
42. M.S. Finkel, C.V. Oddis, T.D. Jacob, S.C. Watkins, B.G. Hattler, and R.L. Simmons Negative inotropic effects of cytokines on the heart mediated by nitric oxide Science 257 1992 387 389
43. M. Odeh, E. Sabo, and A. Oliven Circulating levels of tumor necrosis factor-alpha correlate positively with severity of peripheral oedema in patients with right heart failure Eur J Heart Fail 8 2006 141 146
44. J. Nagendran, S.L. Archer, and D. Soliman Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility Circulation 116 2007 238 248
45. A. Reichenbach, H. Al-Hiti, and I. Malek The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study Int J Cardiol 168 2013 60 65
46. T. Agustsson, P. Wikrantz, M. Ryden, T. Brismar, and B. Isaksson Adipose tissue volume is decreased in recently diagnosed cancer patients with cachexia Nutrition 28 2012 851 855
47. M. Fouladiun, U. Korner, I. Bosaeus, P. Daneryd, A. Hyltander, and K.G. Lundholm Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care - correlations with food intake, metabolism, exercise capacity, and hormones Cancer 103 2005 2189 2198
48. A. Zavin, K. Daniels, and R. Arena Adiposity facilitates increased strength capacity in heart failure patients with reduced ejection fraction Int J Cardiol 167 2013 2468 2471
49. C.J. Lavie, A. De Schutter, D.A. Patel, A. Romero-Corral, S.M. Artham, and R.V. Milani Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox." J Am Coll Cardiol 60 2012 1374 1380
50. E.G. Artero, D.C. Lee, and C.J. Lavie Effects of muscular strength on cardiovascular risk factors and prognosis J Cardiopul Rehab Preven 32 2012 351 358